SHEEL — Sheel Biotech Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 15.76% | ||
Return on Equity | 13.59% | ||
Operating Margin | 13.83% |
Financial Summary
Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | n/a | 707.36 | 801.16 | 922.82 | 1,017.52 | n/a | n/a | 12.88% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | +13.28 | +107.03 | +0.31 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Sheel Biotech Limited is an India-based company, which is engaged in the business of growing, developing, processing, and supplying a range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. The Company's business vertical includes tissue culture, planting material, hortiprojects, Sheel berries, farmer producer organization, organic adoption and certifications, speed breeding facility, and skill development. It operates one plant tissue culture labs in North India, located in Manesar, Gurugram. Its hortiprojects services include greenhouse, centres of excellence (COE), integrated packhouse and turnkey projects. Its Sheel berries plants include blueberry plants, strawberry plants and raspberry plants. It helps with organic certification through both National Programme for Organic Production and Participatory Guarantee Systems India. It offers services to farmers and provides training through Farmer Producer Organizations.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- January 1st, 1970
- Incorporated
- November 26th, 1991
- Public Since
- October 8th, 2025
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
National Stock Exchange of India
- Shares in Issue
- 20,352,550

- Address
- NEW DELHI, 110019
- Web
- https://sheelbiotech.com/
- Phone
- Auditors
- Rajan k. Gupta & Co.
Similar to SHEEL
ADF Foods
National Stock Exchange of India
Agri-Tech (India)
National Stock Exchange of India
Ajooni Biotech
National Stock Exchange of India
Anik Industries
National Stock Exchange of India
Annapurna Swadisht
National Stock Exchange of India
FAQ
As of Today at 23:11 UTC, shares in Sheel Biotech are trading at IN₹86.30. This share price information is delayed by 15 minutes.
Shares in Sheel Biotech last closed at IN₹86.30 and the price had moved by over the past 365 days. In terms of relative price strength the Sheel Biotech share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreSheel Biotech does not currently pay a dividend.
Sheel Biotech does not currently pay a dividend.
Sheel Biotech does not currently pay a dividend.
To buy shares in Sheel Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹86.30, shares in Sheel Biotech had a market capitalisation of .
Here are the trading details for Sheel Biotech:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SHEEL
Based on an overall assessment of its quality, value and momentum Sheel Biotech is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sheel Biotech. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹86.30, shares in Sheel Biotech were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sheel Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹86.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Sheel Biotech's directors